Home  >  Products  >  Iso-Sensitest Agar
Iso-Sensitest Agar

Iso-Sensitest Agar

Cat no: I9090

Supplier: United States Biological
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
Read More on Supplier Website
Iso-Sensitest Agar is a medium developed specifically for anti-microbial susceptibility tests like the Disc Diffusion Method. This is a well-defined medium containing a stabilized mineral content to avoid antagonism to certain antimicrobials by metal ions. It allows the growth of the great majority of microorganisms without further supplementation. It can also be supplemented for fastidious organisms with 5% whole horse blood or 5% whole horse blood and 20mg/l beta-nicotinamide adenine dinucleotide (NAD). Some mutant strains which are totally dependent on thymine and thymidine for their growth will not grow on Iso-Sensitest Agar which has these two components at very low levels. Care must be taken to recognize these strains. Certain supplements interefere with anti-microbial activity and tests must be performed to measure their effect. These supplements and the anti-microbial agents affected (in parentheses) include: thymidine (trimethoprim), blood (sulfonamides, trimethoprim, aminoglycosides), carbon dioxide (aminoglycosides, erythromycin, lincomycin, tetracycline, novobiocin), cysteine and other sulfhydryl compounds (aminoglycosides), and Vitox/Isovitalex (sulfonamides, trimethoprim). The addition of lysed horse erthrocytes to the medium is not required when carrying out anti-microbial susceptibility tests with trimethoprim and sulfonamides
Catalogue number: I9090
Size: 500g
References: 1. Ericsson H. M. and Sherris J. C. (1971) Acta. Pathol. Microbiol. Scand. Suppl. 217. 1-90. 2. Garrod L. P. and Waterworth P. M. (1971) J. Clin. Path. 24. 779-789. 3. Reller L. B., Schoenknecht F. D., Kenny M. A. and Sherris J. C. (1974) J. Infect. Dis. 130. 454-463. 4. Duncan I. B. R. (1974) Antimicrob. Agents & Chemotherapy 5. 9-15. 5. Yourassowsky E., Vanderlinden M. P. and Schoutens E. (1974) J. Clin. Path. 27. 897-901. 6. Neussil H. (1976) Chemotherapy Vol.2. 33-40. 7. Bridson E. Y. (1976) Arztl. Lab. 22. 373-376. 8. Tanner E. I. and Bullin C. H. (1974) J. Clin. Path. 27. 565-568. 9. Thomas M. and Bond L. (1973) Med. Lab. Technol. 30. 277-279. 10. Barker J., Healing D. and Hutchinson J. G. P. (1972) J. Clin. Path. 25. 1086-1088. 11. Reynolds A. V., Hamilton-Miller J. M. T. and Brumfitt W. (1974) B.M.J. (ii) 778. 12. Stewart Sheila M., Anderson Isobel M. E. and Malcolm Margaret G. G. (1975) J. Clin. Path. 28. 195-197. 13. Bell S. M. (1975) Pathology 7. Suppl. 1-48. 14. Garrod L. P. and Waterworth P. M. (1969) J. Clin. Path. 22. 534-538. 15. Gilbert D. N., Kutscher E., Ireland P., Barnett J. A. and Sandford J. P. (1971) J. Infect. Dis. 124. (suppl.), S37-S45. 16. Zimelis V. M. and Jackson G. G. (1973) J. Infect. Dis. 127. 663-669. 17. Davis S. D., Ianetta A., Wedgewood R. J. (1971) J. Infect. Dis. 124. 610-612. 18. Brenner V. C. and Sherris J. C. (1972) Antimicrob. Agents Chemother. 1. 116-122. 19. Traub W. H. (1970) Appl. Microbiol. 20. 98-102. 20. Acar J. F. (1980) Antibiotics in Laboratory Medicine, Lorian V. (Ed.) Williams and Wilkens, Baltimore, USA, 48-51. 21. Hartzen S.H., Andersen L.P., Bremmelgaard A. et al (1997) Antimicrob. Ag. and Chemother. 41. 2634-2639. 22. British Society for Antimicrobial Chemotherapy (2002) Disc Diffusion Method for Antimicrobial Susceptibility Testing. Version 2.1.1. BSAC.

Get Quote

  • Best Price Guaranteed
  • Quick Response Time
  • Exclusive Promotions
Enquiry_down_arrow
United States Biological
Get a Quote Direct from
United States Biological

By submitting this form you agree to your details being passed to United States Biological for the purpose of generating the best quote*
See Full Product Listings >
Button_on Button_off_biosave Button_off_biosave Button_off_biosave Button_off_biosave Button_off_biosave Button_off_biosave